INNOMICS INC.

INNOMICS INC. specializes in advanced genomic data analysis and transcriptome resequencing services, delivering high-throughput sequencing solutions for biomedical research and clinical applications. The company leverages next-generation sequencing technologies, bioinformatics pipelines, and computational biology tools to decode gene expression patterns and identify molecular signatures in complex biological samples. Their technical expertise includes RNA-seq data processing, variant calling, differential expression analysis, and transcriptome assembly—critical for understanding disease mechanisms and advancing precision medicine. INNOMICS differentiates itself through rigorous data integrity protocols and domain-specific algorithm development tailored to NIH-funded research environments. The contractor has demonstrated direct engagement with the Department of Health and Human Services, primarily supporting the National Institute of Child Health and Human Development in genomic research initiatives. Their work centers on generating and interpreting transcriptomic datasets that inform developmental biology and pediatric health studies, reflecting a focused, mission-aligned partnership with HHS-funded institutes. INNOMICS operates primarily within the medical laboratories sector (NAICS 621511), where their capabilities translate into specialized diagnostic genomics services for public health research. They serve the biomedical research vertical, providing analytical infrastructure that bridges laboratory-generated sequencing data with actionable biological insights—positioning them as a niche provider in translational genomics for federal science agencies. As a small business structured as a 2L entity based in Cambridge, Massachusetts, INNOMICS benefits from proximity to leading academic and biotech institutions. While no formal government certifications are currently listed, their operational model is aligned with federal research standards, and their geographic presence in the Boston innovation corridor supports deep collaboration with NIH and other life sciences stakeholders.